Add Yahoo as a preferred source to see more of our stories on Google. (COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in ...
PreEvnt isaac device uses breath analysis to monitor glucose levels without needles, drawing attention at CES 2026 as a ...
In today’s fast-paced world, managing health conditions like diabetes has become more crucial than ever. With over 463 million people worldwide grappling with diabetes—a number that continues to rise ...
Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.
Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive blood sugar tracking.
A new kind of wearable wristband could reshape how people with diabetes understand and manage their health. In addition to checking blood sugar, this wearable checks a series of important indicators ...
A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, ...
This diabetes technology offers a continuous stream of data to show a more complete picture of your blood sugars over time. This is different from a fingerstick meter that only represents that moment.
StockStory.org on MSN
Patient monitoring stocks Q3 earnings: iRhythm (NASDAQ:IRTC) best of the bunch
Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including ...
It’s an increasingly common posttreatment occurrence: Patients with hypertension or diabetes return home with new blood pressure or glucose monitors, allowing clinicians to keep tabs on patient ...
INDIANAPOLIS, Ind. (Ivanhoe Newswire) - More than 38 million Americans have diabetes and regular blood sugar monitoring is crucial. A team of researchers is working on a new way to do that, and it’s ...
Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results